The KEGG enrichment analyses highlighted proliferation- and migration-related pathways, including the MAPK signaling pathway, PI3K/Akt cascade, cell adhesion molecules (CAMs), and cytokine-cytokine receptor interaction, which also suggests that the PAM treatment could affect lung cancer cell function through those downstream pathways. The gene discussed is AKT1; the disease is lung cancer.